Back to the feed
In brief
On 15.11.2024, a person holding the function "Non-executive member of the board of directors" at Kuros Biosciences AG disclosed a purchase worth CHF 925’210 to SIX Exchange Regulation.
This is the largest management purchase disclosed at Kuros Biosciences AG over the previous 12 months (13 purchases in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A non-executive member of the board of directors of Kuros Biosciences AG declared a "Purchase" transaction on 15.11.2024.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date15.11.2024
Issuing companyKuros Biosciences AG
ISINCH0325814116
Transaction sidePurchase
Management functionNon-executive member of the board of directors
Security typeRegistered shares
Quantity32’350
Unit priceCHF 28.60
AmountCHF 925’210
Conditions(i) the report is a corrected report and (ii)
Correction: The trade was not executed by a related
natural person
ExchangeXSWX
Notification IDT1OBF00075
Other Kuros Biosciences AG insider transactions
- Purchase · Executive member of the board of directors / senior management19.10.2026CHF 282’505
- Sale · Executive member of the board of directors / senior management06.10.2026CHF 552’000
- Purchase · Executive member of the board of directors / senior management22.09.2026CHF 30’600
- Purchase · Executive member of the board of directors / senior management17.09.2026CHF 115’322
- Sale · Executive member of the board of directors / senior management26.05.2026CHF 139’385
These figures aggregate public disclosures. They are not investment advice.